Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Ibutilide

Michael W. Szymanski  1 , Mark V. Pellegrini, Manouchkathe Cassagnol  2
In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan.
.
Affiliations
Free Books & Documents
Book

Ibutilide

Michael W. Szymanski et al.
Free Books & Documents

Excerpt

Ibutilide is a class III antiarrhythmic medication approved by the US Food and Drug Administration (FDA) for converting acute atrial flutter and atrial fibrillation to normal sinus rhythm. Studies indicate ibutilide's greater efficacy in treating atrial flutter than atrial fibrillation. In addition to its FDA-approved indications, ibutilide is commonly used off-label as a pretreatment for electro-cardioversion and may also be administered post-cardioversion to prevent recurrent atrial fibrillation. Moreover, ibutilide administration might be necessary following surgery. Ibutilide functions as a potassium channel blocker, extending phase 3 of the cardiac action potential. This leads to heightened refractoriness of atrial and ventricular myocytes, along with the atrioventricular node and the His-Purkinje system.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Michael Szymanski declares no relevant financial relationships with ineligible companies.

Disclosure: Mark Pellegrini declares no relevant financial relationships with ineligible companies.

Disclosure: Manouchkathe Cassagnol declares no relevant financial relationships with ineligible companies.

References

    1. Murray KT. Ibutilide. Circulation. 1998 Feb 10;97(5):493-7. - PubMed
    1. Kowey PR, Stoenescu ML. Selection of drugs in pursuit of a rhythm control strategy. Prog Cardiovasc Dis. 2005 Sep-Oct;48(2):139-45. - PubMed
    1. Oral H, Souza JJ, Michaud GF, Knight BP, Goyal R, Strickberger SA, Morady F. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med. 1999 Jun 17;340(24):1849-54. - PubMed
    1. VanderLugt JT, Mattioni T, Denker S, Torchiana D, Ahern T, Wakefield LK, Perry KT, Kowey PR. Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery. Circulation. 1999 Jul 27;100(4):369-75. - PubMed
    1. Yang T, Snyders DJ, Roden DM. Ibutilide, a methanesulfonanilide antiarrhythmic, is a potent blocker of the rapidly activating delayed rectifier K+ current (IKr) in AT-1 cells. Concentration-, time-, voltage-, and use-dependent effects. Circulation. 1995 Mar 15;91(6):1799-806. - PubMed

Publication types

LinkOut - more resources